NOT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Novartis AG

Watchlist Manager

Watchlist

Price: 139.52 EUR -0.43%

Market Cap: €286.8B

N	Novartis AG DUS:NOT	CH
L	Laboratorios Richmond SACIF BCBA:RICH	AR
	Prodia Widyahusada Tbk PT IDX:PRDA	ID
A	Altria Group Inc F:PHM7	US
F	Fresenius Medical Care AG & Co KGaA F:FME	DE
N	Nebius Group NV F:YDX	NL
C	Costco Wholesale Corp SWB:CTO	US

Profitability Summary

Novartis AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

73% > 75%

Exceptional Operating Margin

32%

Strong 3Y Average Operating Margin

31%

Operating Margin is Increasing

20% > 32%

Healthy Net Margin

17%

Sustainable 3Y Average Net Margin

27%

Net Margin is Increasing

17% > 17%

Exceptional Free Cash Flow Margin

24%

Strong 3Y Average Free Cash Flow Margin

27%

Declining Free Cash Flow Margin

28% > 24%

Positive ROE

25%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

16%

ROIC is Increasing

8% > 15%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.